Physician profile
Stephen Penny
NPI 1881691236
$2,074.04
in general payments reported to CMS, 2019-2025
21 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $70.31 · 2021: $119 · 2022: $264 · 2023: $473 · 2024: $290 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $542.20 | 2019-2023 | Vumerity |
| Lilly USA, LLC | $262.90 | 2019-2024 | Reyvow, Emgality |
| Celgene Corporation | $145.80 | 2022-2023 | Zeposia |
| Ucb, INC. | $125.00 | 2024 | Rystiggo |
| Jazz Pharmaceuticals INC. | $122.00 | 2023 | Xywav |
| Otsuka America Pharmaceutical, INC. | $121.60 | 2023 | Rexulti |
| Sunovion Pharmaceuticals INC. | $111.20 | 2019-2020 | |
| Medtronic USA, INC. | $102.26 | 2019 | |
| Abbvie INC. | $97.85 | 2021-2025 | |
| Allergan, INC. | $95.54 | 2019-2021 | |
| Amgen INC. | $64.05 | 2021-2024 | Uplizna |
| Novartis Pharmaceuticals Corporation | $49.53 | 2019-2021 | |
| Life Molecular Imaging LTD | $48.23 | 2025 | Neuraceq |
| Alexion Pharmaceuticals, INC. | $35.62 | 2022 | |
| Pfizer INC. | $35.59 | 2023-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $27.49 | 2025 | Exablate |
| Amneal Pharmaceuticals LLC | $20.39 | 2025 | Crexont |
| Abbott Laboratories | $19.15 | 2023 | Penta |
| Acadia Pharmaceuticals INC | $17.11 | 2023 | Nuplazid |
| Emd Serono, INC. | $16.46 | 2019 | |
| Kyowa Kirin, INC. | $14.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Penny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.